Rebate Reshuffle Could Pharma Foot The Bill To Offset Higher Premiums
Rebate Reshuffle: Could Pharma Foot The Bill To Offset Higher Premiums?
13:08 EDT 8 Apr 2019 |
SCRIP
Bernstein Research analysts said CMS could charge pharmaceutical manufactures a fee to offset increases in insurance premiums anticipated from the...
Original Article: Rebate Reshuffle: Could Pharma Foot The Bill To Offset Higher Premiums?
More From BioPortfolio on "Rebate Reshuffle: Could Pharma Foot The Bill To Offset Higher Premiums?"